(Total Views: 135)
Posted On: 10/05/2023 9:06:57 AM
Post# of 1
TREACE MEDICAL: HELPING BUNION PATIENTS “STEP” AHEAD
$TMCI
Excited to share an article about Treace Medical Concepts, Inc. (NasdaqGS: TMCI), a medical technology company that is revolutionizing the surgical treatment of hallux valgus, commonly known as bunions, through its Lapiplasty® 3D Bunion Correction™ Procedure.
Treace has been experiencing an exponential increase in revenue over the last few quarters. In Q2 FY23, the company recorded revenues of $42 million, a 40% increase compared to last year. For FY22, the revenue was $141.8 million, representing a 50% YoY increase.
This growth trend is expected to continue in the future. Treace's proprietary Lapiplasty System is minimally invasive with a low risk of recurrence, making it superior to existing treatment options. This presents an opportunity for Treace to capture a significant share of the $5+ billion market opportunity.
Read on to know more:
https://www.aviseanalytics.com/treace-medical...step-ahead
$TMCI
Excited to share an article about Treace Medical Concepts, Inc. (NasdaqGS: TMCI), a medical technology company that is revolutionizing the surgical treatment of hallux valgus, commonly known as bunions, through its Lapiplasty® 3D Bunion Correction™ Procedure.
Treace has been experiencing an exponential increase in revenue over the last few quarters. In Q2 FY23, the company recorded revenues of $42 million, a 40% increase compared to last year. For FY22, the revenue was $141.8 million, representing a 50% YoY increase.
This growth trend is expected to continue in the future. Treace's proprietary Lapiplasty System is minimally invasive with a low risk of recurrence, making it superior to existing treatment options. This presents an opportunity for Treace to capture a significant share of the $5+ billion market opportunity.
Read on to know more:
https://www.aviseanalytics.com/treace-medical...step-ahead
(0)
(0)
